Tricida, Inc. is building out its leadership team with key regulatory and administrative hires. Claire Lockey was appointed to the position of Chief Development Officer and Senior Vice President, where she will oversee Tricida's regulatory affairs, quality assurance, and project management. Edward J. Hejlek, J.D., joined Tricida as General Counsel and Senior Vice President, where he will be responsible for overseeing corporate, intellectual property and transactional legal activities on behalf of the company.

Ms. Lockey joins Tricida from Relypsa, Inc., where she led the regulatory efforts leading to FDA approval of Relypsa's novel hyperkalemia treatment Veltassa™ (patiromer). Mr. Hejlek was most recently a partner in the St. Louis and San Francisco offices of the national law firm Bryan Cave LLP, and before that practiced at the St.

Louis firm Senniger Powers LLP.